Aromics

MainImage

299,832.91€

Out of 300,000.00€

investors

38

Est. ROI

614%

days left

--

Developing a novel treatment for malignant mesothelioma

Finish date: 01/04/2017 Barcelona

Premoney valuation

5,000,000.00€

Percentage offered

5.66%

Est. ROI

614%

Exit horizon

2021

Understand the risks associated with your investments, review all project documentation and ask any questions you have. We will be happy to assist.